Rocket Pharmaceuticals reported the appointment of Fady Malik, M.D., Ph.D., to its Board of Directors. According to a media release, Dr. Malik brings nearly 25 years of experience as an internationally recognized cardiovascular physician-scientist and biopharmaceutical executive. He will serve as an independent non-executive director.

Dr. Malik is Executive Vice President of Research and Development at Cytokinetics, a late-stage biopharmaceutical company, where he has worked in a variety of positions since he joined the founders to launch the company.